Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Association of comorbid personality disorders with clinical characteristics and outcome in a randomized controlled trial comparing two psychotherapies for early-onset persistent depressive disorder

Nele Erkens*, Elisabeth Schramm, Levente Kriston, Martin Hautzinger, Martin Härter, Ulrich Schweiger, Jan Philipp Klein

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Background: Persistent depressive disorder (PDD) is associated with high rates of comorbid personality disorders (PD). The association of comorbid PD and clinical characteristics has not been systematically studied in PDD. Results regarding effects on treatment outcome are heterogeneous. Methods: We analyzed the association of comorbid personality disorders with clinical characteristics and outcome in a randomized controlled trial comparing the disorder-specific Cognitive Behavioral Analysis System of Psychotherapy (CBASP) with nonspecific supportive psychotherapy (SP) in patients with early-onset PDD. The main outcome measure was the Hamilton Rating Scale for Depression (HRSD-24). Further baseline measures were comorbid axis-I diagnoses (SCID-I), quality of life (QLDS), global functioning (GAF), interpersonal problems (IIP-64) and childhood maltreatment (CTQ). Results: Out of the 268 patients, 103 (38.4%) met criteria for at least one PD. PD was associated with higher rates of axis I comorbidities (mainly anxiety disorders) and interpersonal problems (patients with PD were more vindictive, more self-sacrificing, less assertive and more inhibited socially than patients without PD). There was no significant main effect of PD on treatment outcome and no significant interaction between PD and treatment group. Limitations: The main limitation was the exclusion of patients with certain personality disorders (antisocial, schizotypal, and borderline personality disorders). Furthermore, the study was underpowered to find interaction effects of small size. Conclusion: Persistently depressed patients with and without comorbid PD primarily seemed to differ in the rate of axis I comorbidity and the severity of interpersonal problems. Treatment outcomes appear to be not significantly affected by the presence of PD.

OriginalspracheEnglisch
ZeitschriftJournal of Affective Disorders
Jahrgang229
Seiten (von - bis)262-268
Seitenumfang7
ISSN0165-0327
DOIs
PublikationsstatusVeröffentlicht - 15.03.2018

Fördermittel

The study that this analysis was based on was designed and headed by Elisabeth Schramm (University of Freiburg), Martin Härter and Levente Kriston (University Medical Center Hamburg-Eppendorf), and Martin Hautzinger (Eberhard Karls University Tübingen). It was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) with the title "A comparison of the Cognitive Behavioural Analysis System of Psychotherapy (CBASP) with the System of Supportive Psychotherapy (SYSP) for Early Onset Chronic Depression" (grant number SCHR443/11-1 ). In addition to the leading investigators, substantial design, coordinating, or data management tasks were performed by Ingo Zobel, Mathias Berger, Paul Bausch, Thomas Fangmaier (University of Freiburg), and Ramona Meister (University Medical Center Hamburg). Clinical trial sites were Freiburg (headed by Elisabeth Schramm), Tübingen (Martin Hautzinger), Mannheim (Joseph Bailer), Marburg (Katrin Wambach), Heidelberg/Stuttgart (Matthias Backenstrass and Knut Schnell), Lübeck (Philipp Klein), Bonn (Dieter Schoepf), and Hamburg (Antje Gumz and Bernd Löwe). The study that this report is based on was funded by a grant of the German Research Foundation (SCHR443/11-1). The funding body had no role in the design of the study, data collection, analysis or interpretation of the data. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 10 – Weniger Ungleichheiten
    SDG 10 – Weniger Ungleichheiten

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Association of comorbid personality disorders with clinical characteristics and outcome in a randomized controlled trial comparing two psychotherapies for early-onset persistent depressive disorder“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren